Additionally, increased CENP-A expression is implicated in malignant progression (Sun et al., 2016) and correlates with poor prognosis in cancers (Zhang et al., 2020a; Saha et al., 2020; Xu et al., 2020), including breast (Rajput et al., 2011), lung (Wu et al., 2012; Liu et al., 2018), and hepatic carcinoma (Zhang et al., 2020b). The gene discussed is CENPA; the disease is cancer.